跳至主要内容
临床试验/NCT03544788
NCT03544788撤回不适用

HEAL I (The Treatment of Venous Leg Ulcers): Evaluation of Cirvo™ Mobile Compression Device for the Treatment of Venous Leg Ulcers

Radial Medical, Inc.2 个研究点 分布在 1 个国家开始时间: 2019年6月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Percent of subjects fully healed at 12 weeks

研究概览

简要总结

This study in venous leg ulcer (VLU) patients will evaluate the use of Cirvo™ therapy for the treatment of VLU when applied for a minimum of two hours daily for up to 12 weeks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients between 18 and 80 years of age
  • Patients (CEAP 6) who have not previously experienced a period of open ulceration exceeding 26 weeks in the affected leg
  • Total venous ulcer area < 20cm2
  • Duration of therapy for active venous ulcer <26 weeks prior to enrollment
  • Venous insufficiency documented by venous reflex ultrasound showing mild, moderate, or severe reflux in the superficial or deep venous system

排除标准

  • Acute DVT within the 3 months prior to enrollment
  • Ulcer present for <2 weeks
  • Ulcers extending with exposed fascia, tendon, or bone within the wound margins
  • Lateral malleolus ulcers
  • Ulcers with perforator incompetence deep to the ulceration (within 5 cm of the wound border)
  • Active infection (systemic or in the affected limb)
  • Lower extremity gangrene
  • Diabetes mellitus (Type I or II) requiring medication
  • History of pulmonary vascular disease (PVD)
  • History of pulmonary edema
  • History of decompensated congestive heart failure (CHF)
  • Open surgery or major trauma to the legs within the last six months
  • History of lower limb malignancy, primary or secondary
  • Acute symptomatic lower extremity thrombophlebitis
  • Pregnant or breastfeeding
  • Calf geometry on which Cirvo(TM) device does not appropriately fit
  • Known sensitivity to any of the materials used in the Cirvo(TM) device
  • Currently participating or plans to participate in in any other investigational clinical evaluation during the 12 week study period that may, in the opinion of the investigator, affect blood flow and/or venous leg ulcer

研究组 & 干预措施

Cirvo™ Therapy

Experimental

干预措施: Cirvo™ Therapy (Device)

结局指标

主要结局

Percent of subjects fully healed at 12 weeks

时间窗: 12 weeks

次要结局

  • Percent of wound epithelialized at 12 weeks(12 weeks)
  • Percent of subjects fully healed at 4 weeks(4 weeks)

研究者

发起方
Radial Medical, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验